BRIEF published on 05/14/2025 at 16:46, 1 year 3 months ago Vanguard Group Discloses Position in Primary Health Properties Takeover Code Vanguard Group Financial Regulations Shareholding Disclosure Primary Health Properties
PRESS RELEASE published on 05/14/2025 at 16:45, 1 year 3 months ago Form 8.3 - The Vanguard Group, Inc.: Dalata Hotel Group plc The Vanguard Group, Inc. discloses a 3.34% ownership in Dalata Hotel Group plc as per Form 8.3 with relevant securities information Form 8.3 Vanguard Group Ownership Disclosure Dalata Hotel Group Securities Information
BRIEF published on 05/14/2025 at 16:44, 1 year 3 months ago The Vanguard Group Discloses Position in Assura plc Form 8.3 Takeover Code Securities Disclosure Vanguard Group Assura Plc
PRESS RELEASE published on 05/14/2025 at 16:43, 1 year 3 months ago Form 8.3 - The Vanguard Group, Inc.: Spirent Communications plc The Vanguard Group, Inc. discloses 5.16% stake in Spirent Communications plc. Purchase of 81,234 shares at 1.91 GBP per share on 13th May 2025 Vanguard Group Financial Disclosure Share Purchase Stake Disclosure Spirent Communications
BRIEF published on 05/14/2025 at 16:42, 1 year 3 months ago The Vanguard Group Discloses Position in Greencore Group Form 8.3 Takeover Code Vanguard Group Shares Disclosure Greencore Group
PRESS RELEASE published on 05/14/2025 at 16:41, 1 year 3 months ago Form 8.3 - The Vanguard Group, Inc.: Primary Health Properties plc The Vanguard Group, Inc. discloses a 5.60% ownership in Primary Health Properties plc's 12.5p ordinary shares. Details of acquisitions and disposals provided The Vanguard Group Ownership Disclosure Primary Health Properties Plc Acquisitions And Disposals Relevent Securities
BRIEF published on 05/14/2025 at 16:40, 1 year 3 months ago The Vanguard Group Discloses Position in Bakkavor Group plc Disclosure Takeover Code Vanguard Group Securities Position Bakkavor Group
PRESS RELEASE published on 05/14/2025 at 16:39, 1 year 3 months ago Form 8.3 - The Vanguard Group, Inc.: Assura plc The Vanguard Group, Inc. discloses a 5.67% ownership in Assura plc. Details on positions, dealings, and disclosures provided Financial Dealings The Vanguard Group Ownership Disclosure Stock Positions Assura Plc
PRESS RELEASE published on 05/14/2025 at 16:37, 1 year 3 months ago Form 8.3 - The Vanguard Group, Inc.: Greencore Group plc The Vanguard Group, Inc. discloses a 5.40% stake in Greencore Group plc. Purchase of 1p ordinary securities at 1.89 GBP per unit Vanguard Group Financial Disclosure Stake Disclosure Securities Purchase Greencore Group
BRIEF published on 05/14/2025 at 16:37, 1 year 3 months ago The Vanguard Group Discloses Significant Stake in Aviva plc Form 8.3 Disclosure The Vanguard Group Takeover Code Aviva Plc
Published on 09/11/2026 at 04:00, 7 hours 29 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 13 hours 4 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 20 hours 9 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 20 hours 29 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 10:15, 1 hour 14 minutes ago TCMA Receives Two National Awards, Highlighting Thailand’s Cement Industry Progress Towards Net Zero 2050
Published on 09/11/2026 at 09:20, 2 hours 9 minutes ago Cantourage Expands Portfolio with New Cannabis Active Ingredients for Innovative Compounded Medicines
Published on 09/11/2026 at 09:05, 2 hours 24 minutes ago ROHM's New High Anti-surge Chip Resistors in "SDR01 Series" Achieve 0.33W Rated Power in 0402 Size
Published on 09/11/2026 at 09:00, 2 hours 29 minutes ago Homann Holzwerkstoffe publishes its 2026 half-year report
Published on 09/11/2026 at 07:00, 4 hours 29 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/10/2026 at 19:30, 15 hours 59 minutes ago Availability of the 2026 Interim Financial Report
